Showing results (51-60 of 484) with videos related to
Sort By:
Pageof 49
Ugeskrift for Laeger|May 6, 2008
[Osteoporosis and fractures associated with drugs]Peter Vestergaard, Lars Rejnmark, Leif MosekildeCurrent Drug Safety|April 29, 2011
Medical treatment of primary, secondary, and tertiary hyperparathyroidismPeter Vestergaard, Susanna vid Strym ThomsenScandinavian Journal of Public Health|July 25, 2006
Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from DenmarkPeter Vestergaard, Lars Rejnmark, Leif MosekildeBMJ Clinical Evidence|May 6, 2011
Fracture prevention in postmenopausal womenPeter Vestergaard, Leif Mosekilde, Bente LangdahlUgeskrift for Laeger|February 1, 2011
[Denosumab--a new efficient osteoporosis therapy]Lars Rejnmark, Peter Vestergaard, Leif MosekildeJournal of Hypertension|February 10, 2006
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control studyLars Rejnmark, Peter Vestergaard, Leif MosekildeMaturitas|January 18, 2006
Fracture reducing potential of hormone replacement therapy on a population levelPeter Vestergaard, Lars Rejnmark, Leif MosekildeOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 16, 2004
Osteoporosis is markedly underdiagnosed: a nationwide study from DenmarkPeter Vestergaard, Lars Rejnmark, Leif MosekildeActa Orthopaedica|November 18, 2009
Loss of life years after a hip fracturePeter Vestergaard, Lars Rejnmark, Leif MosekildeActa Oncologica (Stockholm, Sweden)|July 9, 2008
Fracture risk in patients with different types of cancerPeter Vestergaard, Lars Rejnmark, Leif MosekildePageof 49